PROTECH C2I CANINE CORONAVIRUS & LEPTOSPIRA COPENHAGENI KILLED VACCINE

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

LEPTOSPIRA ICTEROHAEMORRHAGIAE ANTIGEN; CANINE CORONAVIRUS VACCINE - ANTIGEN

Available from:

Boehringer Ingelheim Animal Health Australia Pty. Ltd.

INN (International Name):

canine coronavirus+vaccine - leptospirosis

Pharmaceutical form:

MISC. VACCINES OR ANTI SERA

Composition:

LEPTOSPIRA ICTEROHAEMORRHAGIAE ANTIGEN VACCINE-ANTIGEN Active 1.0 RP; CANINE CORONAVIRUS VACCINE - ANTIGEN VACCINE-VIRAL Active 1.62 RP

Units in package:

10 x 1mL; 25 x 1mL

Class:

VM - Veterinary Medicine

Therapeutic group:

DOG - OVER 6 WEEKS OLD

Therapeutic area:

IMMUNOTHERAPY

Therapeutic indications:

CANINE ADENOVIRUS - TYPE 1 | CANINE ADENOVIRUS - TYPE 2 | CANINE CORONAVIRUS | CANINE DISTEMPER | CANINE PARAINFLUENZA | CANINE PARVOVIRUS | LEPTOSPIRA ICTEROHAEMORRHAGIAE | PARVOVIRUS

Product summary:

Poison schedule: 0; Withholding period: WHP: N/A; Host/pest details: DOG - OVER 6 WEEKS OLD: [CANINE ADENOVIRUS - TYPE 1, CANINE ADENOVIRUS - TYPE 2, CANINE CORONAVIRUS, CANINE DISTEMPER, CANINE PARAINFLUENZA, CANINE PARVOVIRUS, LEPTOSPIRA ICTEROHAEMORRHAGIAE]; For the immunisation of healthy dogs, 6 weeks of age or older to protect against disease caused by Leptospira copenhageni and aid in protection against disease caused by canine coronavirus.Can be used for prevention of clinical disease, however, it may fail to prevent infection or organism shedding. See DIRECTIONS FOR USE, PRECAUTIONS and SIDE EFFECTS information on label.

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

Protech C2i Canine Coronavirus
&
Leptospira Copenhageni Killed Vaccine
APVMA51488
Page
1
of
5
11
October 2013
Vial label
FOR ANIMAL TREATMENT ONLY
PROTECH® C2I
CANINE CORONAVIRUS
&
LEPTOSPIRA COPENHAGENI KILLED VACCINE
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
Store between 2-8°C.
Do
not freeze. Protect from light.
APVMA 51488/60396
Batch No.:
Expiry:
Boehringer
lngelheim
RLP
Approved
Protech C2i
Canine
Coronavirus & Leptospira Copenhageni Killed
Vaccine
APVMA
51488
Page 2
of
5
11
October
2013
Tray
label-
10
FOR
ANIMAL TREATMENT ONLY
PROTECH®
C2I
CANINE CORONAVIRUS
&
LEPTOSPIRA COPENHAGENI KILLED VACCINE
An
inactivated vaccine prepared from
virulent
canine
coronav
irus (RP
~
1.62) and bacterins
of
Leptospira interrogans
serovar
Copenhageni
(RP
~
1.0).
For
the
immunisation
of
healthy dogs, 6
weeks
of
age
or
older
to protect
aga
i
nst
disease
caused
by
Leptospira interrogans
serovar
Copenhageni
and aid in protection
against
disease
caused
by
canine
coronav
irus.
Contents
:
10
single
dose vials
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT.
Store between 2-8°C.
Do
not freeze.
Protect
from light.
APVMA
No
51488/
60396
Batch
No
.:
Expiry:
Protech® C2i is a registered trademark
of
Boehr
i
nger
lnge
lheim Vetmedica Inc. -
used under license.
Please recycle leaflet, label and tray
only
.
Boehringer
lngelheim
'
Protech C2i Canine Coronavirus
&
Leptospira Copenhageni Killed Vaccine
APVMA51488
Page 3
of
5
11
October 2013
Tray
label-
25
FOR ANIMAL TREATMENT ONLY
PROTECH® C2I
CANINE CORONAVIRUS
&
LEPTOSPIRA COPENHAGENI KILLED VACCINE
An
inactivated vaccine prepared from virulent canine coronavirus (RP
<:
1.62) and bacterins of
Leptospira interrogans
serovar Copenhageni (RP
<:
1.0).
For the immunisation of healthy dogs, 6 weeks
of
age or older
to
protect against disease caused by
Leptospira interrogans
serovar Copenhageni and aid
in
protection against disease caused by canine
coronavirus.
Contents:
25
single dose vials
READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT
Store between 2-8"C.
Do not freeze

Summary of Product characteristics

CS: 1.7.2
Page:
1
MATERIAL SAFETY DATA SHEET
4
of
Infosafe No™
LQ08A
August 2011
ISSUED by BOEHRING
Issue Date :
PROTECH C2I
Product Name :
Not classified as hazardous
1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER
PROTECH C2I
PRODUCT NAME
Boehringer Ingelheim Pty. Limited
COMPANY NAME
78 Waterloo Rd North Ryde
NSW 2113 Australia
ADDRESS
1800 038 037
EMERGENCY TEL.
Tel: [phone]
Fax: [phone]
TELEPHONE/FAX
NUMBER
[e-mail]
EMAIL
An inactivated vaccine for the immunisation of healthy dogs, 6 weeks
of age or
older to protect against disease caused by Leptospira interrogans
serovar
Copenhageni and aid in protection against disease caused by canine
coronavirus.
RECOMMENDED USE
2. HAZARDS IDENTIFICATION
Not classified as hazardous
NON-HAZARDOUS SUBSTANCE.
NON-DANGEROUS GOODS.
Hazard classification according to the criteria of NOHSC.
Dangerous goods classification according to the Australia Dangerous
Goods
Code.
HAZARD
CLASSIFICATION
3. COMPOSITION/INFORMATION ON INGREDIENTS
An inactivated vaccine prepared from virulent canine coronavirus
(CCV-TN449
strain, RP . 1.62) and bacterins of Leptospira interrogans serovar
Copenhageni.
INFORMATION ON
COMPOSITION
NAME
CAS
PROPORTION
INGREDIENTS
Ingredients determined
not to be hazardous
-
100 %
4. FIRST AID MEASURES
No special precautions required. However, if inhaled, remove affected
person
from contaminated area. Keep at rest until recovered. If symptoms
persist seek
medical attention.
INHALATION
Do not induce vomiting. Wash out mouth thoroughly with water. If
symptoms
develop seek medical attention.
INGESTION
Wash affected area thoroughly with soap and water. If symptoms develop
seek
medical attention.
Self-Injection: Accidental self injection may lead to an inflammatory
response
and medical advice should be sought on the management of deep
injections,
particularly those near a joint or associated with bruising. If
possible the
application of gentle squeezing pressure with absorbent material (e.g.
facial
tissues) at the injection s